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Abstract
In patients with hepatocellular carcinoma (HCC), natural killer (NK) cell activity decreases
significantly, and the reduced activity may be associated with the progression of HCC. In this
study we evaluated the effects of pulsing with interleukin (IL)-2 and/or IL-12 on the activation
of freshly isolated peripheral blood lymphocytes (PBL) derived from patients with HCC. PBL
obtained from 9 HCC patients, 4 liver cirrhosis patients, and 9 normal subjects were cultured in
the presence of IL-2 and/or IL-12. After 24 h of incubation, the levels of interferon (IFN)-gamma
and tumor necrosis factor (TNF)-alpha presented in the supernatants were determined by enzyme-
linked immunosorbent assay (ELISA). The IFN-gamma and TNF-alpha production of PBL pulsed
by a combination of IL-2 and IL-12 was significantly higher than those of PBL stimulated by
either IL-2 or IL-12 alone. The mRNA encoding perforin, granzyme B, as well as IFN-gamma
and TNF-alpha, were markedly enhanced in PBL stimulated with a combination of IL-12 and
IL-2. The pulsing procedure of IL-12 in combination with IL-2 resulted in the increase of IFN-
gamma and TNF-alpha, and the expression of perforin and granzyme B mRNA in PBL obtained
from HCC patients, as well as in those obtained from normal subjects. These results indicate that
adoptive immunotherapy based on PBL pulsed with a combination of IL-2 and IL-12 may be a
promising adjunctive strategy for HCC treatment.
KEYWORDS: hepatocellular carcinoma(HCC), interleukin(IL)-2, interleukin(IL)-12, interferon(IFN)-
r, granzyme B
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 Eﬀects of Pulsing Procedure of Interleukin-12 in Combination with Interleukin-2 on the Activation of Peripheral Blood Lymphocytes Derived from Patients with Hepatocellular Carcinoma
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In patients with hepatocellular carcinoma (HCC), natural killer (NK) cell activity decreases signiﬁcantly, and the reduced activity may be associated with the progression of HCC. In this study we evaluated the eﬀects of pulsing with interleukin (IL)-2 and/or IL-12 on the activation of freshly isolated peripheral blood lymphocytes(PBL)derived from patients with HCC. PBL obtained from 9 HCC patients, 4 liver cirrhosis patients, and 9 normal subjects were cultured in the presence of IL-2 and/or IL-12. After 24 h of incubation, the levels of interferon (IFN)-γand tumor necrosis factor (TNF)-αpresented in the supernatants were determined by enzyme-linked immunosorbent assay(ELISA). The IFN-γand TNF-αproduction of PBL pulsed by a combination of IL-2 and IL-12 was signiﬁcantly higher than those of PBL stimulated by either IL-2 or IL-12 alone. The mRNA encoding perforin, granzyme B, as well as IFN-γand TNF-α, were markedly enhanced in PBL stimulated with a combination of IL-12 and IL-2. The pulsing procedure of IL-12 in combination with IL-2 resulted in the increase of IFN-γand TNF-α, and the expression of perforin and granzyme B mRNA in PBL obtained from HCC patients, as well as in those obtained from normal subjects.
These results indicate that adoptive immunotherapy based on PBL pulsed with a combination of IL-2 and IL-12 may be a promising adjunctive strategy for HCC treatment.
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H epatocellular carcinoma(HCC)is responsible for signiﬁcant morbidity and mortality in the Japanese adult population. The developments of several therapeutic modalities, such as resection, percutaneous ethanol injec-
tion therapy(PEIT)［1］, and radio-frequency ablation
(RFA)［2, 3］, have enabled curative treatments of small
 
HCC. For unresectable large HCC, lipiodole-
chemoembolization and transcatheter arterial embolization have become the main treatment options［4-6］. How-
ever, HCC is liable to re-occur even after the curative treatment［7-10］. In addition, HCC is one of the malignant neoplasms showing poor response to anticancer agents, and the prognosis of patients with HCC remains poor.
In patients with HCC, the natural killer (NK)cell activity, which is believed to play an important role in
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host anti-tumor defense mechanisms, appears to be signiﬁcantly decreased, and the reduced activity was shown to be associated with the progression of HCC［11,
12］. Interleukin-12 (IL-12), a 75-kDa heterodimeric cytokine released by monocytes/macrophages early after immune stimulation, promotes the cytolytic maturation and proliferation of T, NK, and NKT cells and release of interferon(IFN)-γfrom these eﬀector cells［13-15］.
Based on these ﬁndings, it may be possible to develop strategies to enhance the activation of peripheral blood mononuclear cells with IL-12, which may in turn provide a clue to developing an active immunotherapy for HCC.
The aim of this paper is to report our evaluation of the eﬀects of pulsing with IL-12 and/or IL-2 on the activa-
tion of freshly isolated peripheral blood lymphocytes
(PBL) derived from patients with unresectable large HCC. Our study was carried out to assess a novel therapeutic approach of adoptive immunotherapy for treat-
ing patients with unresectable large HCC.
Materials and Methods
 
Nine patients with unresectable large HCC (7 males and 2 females, median age 70)and four patients with liver cirrhosis(3 males and 1 female,median age 65), admitted to our hospital for diagnosis and treatment, were included in this study. Diagnosis of liver cirrhosis and HCC was based on characteristic clinical,
laboratory, and serological features and ﬁndings of ultra-
sound sonography, abdominal computed tomography,
and angiography. The clinical characteristics of the patients are shown in Table 1. Nine healthy volunteers(7 males and 2 females, median age 36)with no known liver disease served as control subjects. Informed consent was obtained from all patients and healthy control subjects.
γ α
/ Peripheral blood mononuclear cells(PBMC)were isolated by Ficoll-
Hypaque (Pharmacia Biotech, Uppsala, Sweden)
centrifugation from the peripheral blood samples obtained from 9 patients with HCC, 4 patients with liver cirrhosis,
and 9 healthy volunteers. The PBMC were washed three times in phosphate buﬀered saline(PBS)and suspended in 1×10?cells/ml in RPMI 1640 medium (GIBCO Laboratories Life Technologies, Inc., Grand Island,
NY, USA)supplemented with 10 heat-inactivated fetal calf serum(FCS), 100 IU penicillin/ml, 100 mg strepto-
mycin/ml, and 2 mMol of glutamin (culture medium).
The cells were plated in plastic plates(Becton Dickinson and Co., Cockeysville, MD, USA)and incubated for 2 h at 37°C in a humidiﬁed CO?incubator. After the incubation, non-adherent cells were collected and used for the following experiments as peripheral blood lymphocytes
(PBL).
PBL suspended in the culture medium were plated in 96-well microtiter plates(5×10?cells/100μl/well)in the presence or absence of IL-2 and/or IL-12 (R&D Sys-
tems, Minneapolis, MN, USA)at indicated concentra-
tions. After 24 h of incubation at 37°C in 5  CO?, the supernatants were collected and stored at-20°C until the assays of TNF-αand IFN-γ. The levels of TNF-αand IFN-γpresent in the supernatants were determined by commercially available kits(BioSource International, Inc.,
Camarillo, CA, USA).
γ α
Total RNA was prepared from PBL activated by the incubation with IL-2 and/or IL-12 for 24 h, and it was analyzed by reverse transcription-polymerase chain reaction (RT-
PCR) for expressing IFN-γ, TNF-α, perforin, and granzyme B mRNA. The PCR was carried out with complementary deoxyribonucleic acid (cDNA) derived from 100 ng RNA, 1 unit of Taq polymerase(Recom-
binant Taq DNA Polymerase;Takara Shuzo Co., Otsu,
Japan), and reaction kits in a ﬁnal volume of 20μl. The PCR conditions included denaturation at 94°C for 30 sec,
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Table 1  Clinical proﬁles of patients with hepatocellular carcinoma and with liver cirrhosis
 
HCC  LC
 
No.of cases  9  4 Gende(Male/Female) 7/2  3/1 Age(years) 70  65.5 HBV/HCV  1/8  1/3 AIb(3.9-4.9 mg/dl) 3.55(2.73-3.89) 3.59 (3.06-3.96)
AST(11-32 lU/l) 76(23-393) 30(24-152)
ALT(6-39 lU/l) 33(15-288) 18(15-201)
AFP(＜7.0 lU/ml) 415(7-85292) 7.15(2.4-25.4)
PIVKA-ll (＜28 mAU/ml) 16010(225-248400) 14.5(10-26)
ICG R15(%) 33(17.1-53.2) 25.5(23-45.5)
Size of main tumor(cm) 7(1.5-15) -
＊, Values are expressed as Median(Minimum-Maximum).
AFP, alpha-fetoprotein;ALT, alanine aminotransferase;AIb, albu-
min; AST, aspartate aminotrnsferase; HBV, hepatitits B virus;
HCV, hepatitis C virus; PIVKA-ll, protein induced by vitamin K absence or antagonist-ll.
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annealing at 55°C for 1 min, and extension at 72°C for 2 min. Thirty cycles of PCR were performed on each sample, after which the products were separated on 3 agarose gels.
The PCR primers used here for the ampliﬁcation of IFN-γ, TNF-α, perforin, granzyme B, andβ-actin-
speciﬁc sequences were as follows;IFN-γ:5’-GCATC GTTTTGGGTTCTCTTGGCTGTTACTGC-3’(sense strand), 5’-CTCCTTTTTCGCTTCCCTGTTTTAGCT GCTGG-3’(anti-sense strand)TNF-α:5’-GAGTGAC AAGCCTGTAGCCCATGTTGTAGCA-3’(sense strand),
5’-GCAATGATCCCAAAGTAGACCTGCCCAGACT-3’
(anti-sense strand)perforin:5’-GCAATGTGCATGTGTC TGTG-3’(sense strand),5’-TTACCCAGGCTGAGTAC TGCT-3’(anti-sense strand)granzyme B:5’-GGGGAAGC TCCATAAATGTCACCT-3’(sense strand), 5’-TACA CACAAGAAGGCCTCCAGAGT-3’(anti-sense strand)
β-actin:5’-ATCTGGCACCACACCTTCTACATTGA GCTGCG-3’(sense strand), 5’-CGTCATACTCCTGC TTGCTGATCCACATCTGC-3’ (anti-sense strand).
The PCR using these primers yield 427, 444, 572, and 838 bp, respectively.
For multiple group com-
parisons, non-parametric comparisons were assessed by the repeated measure analysis of variance (ANOVA).
When ANOVA indicated diﬀerences among the experi-
mental groups, pairwise comparisons of each group were performed using the Scheﬀe test. A P value less than 0.05 was considered to be statistically signiﬁcant.
Results
γ α
/ We evaluated the dose-dependent eﬀects of IL-2 and/or IL-12 on the activation of freshly isolated PBL by monitoring the production of IFN-γand TNF-α(Fig. 1A-F). PBL obtained from a patient with HCC and from a normal subject were incubated for 24 h with IL-2 alone at concen-
trations ranging from 0.05 to 500 U/ml(Fig. 1A and D),
with IL-12 alone at concentrations ranging from 0.01 to 100 U/ml(Fig. 1B and E), or with 10 U/ml of IL-12 in combination with IL-2 at concentrations ranging from 0.05 to 500 U/ml(Fig. 1C and F). As shown in Fig.
1A, IFN-γwas not detected in the supernatants condi-
tioned by non-activated PBL. The addition of exogenous IL-2 resulted in a slight increase in the IFN-γproduction by PBL (Fig. 1A). On the other hand, low levels of
 
TNF-αwere detected in the supernatants conditioned by non-activated PBL obtained from HCC patients and those from normal subjects (Fig. 1D). The addition of exogenous IL-2 used at various concentrations had no eﬀect on the TNF-α production during the culture of PBL (Fig. 1D).
When PBL were stimulated with IL-12, the produc-
tion of IFN-γand TNF-α increased linearly with the dose of IL-12 in both PBL obtained from HCC patients and those obtained from normal subjects(Fig. 1B and E).
In addition, as can be seen in Fig. 1C and F, the stimulation of PBL by 10 U/ml of IL-12 in combination with IL-2 at various concentrations resulted in dramatic increases in the production of IFN-γand TNF-αin the conditioned supernatants. The eﬀect of the combination of IL-2 and IL-12 on the production of IFN-γ and TNF-αwas always more than that of IL-2 alone over a wide dose range. The same eﬀect was observed on PBL obtained from HCC patients and from normal subjects.
Next, we assessed the time-dependent eﬀects of pulsing with IL-2 alone, IL-12 alone, and a combination of IL-2 and IL-12 on the production of IFN-γ and TNF-αby PBL. PBL(5×10?cells/100μl/well)were cultured in the presence of IL-2(50 U/ml), IL-12(10 U/
ml), or IL-2(50 U/ml)and IL-12(10 U/ml)for 6-48 h at 37°C. At the times indicated, the cultured super-
natants were harvested and assessed for the production of IFN-γand TNF-α.
Data depicted in Fig. 2A show that the production of IFN-γin the conditioned supernatants of PBL stimulated with IL-12 alone or with a combination of IL-2 and IL-12 increased in a time-dependent manner, whereas the level of IFN-γ in the supernatants of PBL stimulated with IL-2 alone did not increase during the culturing period.
The production of TNF-α in the conditioned super-
natants of PBL stimulated with a combination of IL-2 and IL-12 increased in a time-dependent manner. However,
the level of TNF-α in the supernatants conditioned by either IL-2-or IL-12-stimulated PBL did not increase during the culturing period.
We examined the eﬀect of IL-2 alone, IL-12 alone,
and IL-12 in combination with IL-2 on the production of IFN-γand TNF-αby PBL in 9 patients with HCC, 4 patients with liver cirrhosis, and 9 normal subjects(Fig.
3A and B). The analysis with repeated measure ANOVA revealed that there was no signiﬁcant diﬀerence in the IFN-γproduction between PBL obtained from normal subjects, LC patients, and HCC patients (P＝0.692)
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 Fig.1  Production of IFN-γand TNF-αfrom IL-2-and/or IL-12-stimulated peripheral blood lymphocytes(PBL). PBL obtained from a normal
 
subject( )and a patient with hepatocellular carcinoma(HCC)( )were incubated for 24 h with IL-2 at concentrations ranging from 0.05
 
to 500 U/ml(A and D), or with IL-12 at concentrations ranging from 0.01 to 100 U/ml(B and E), or 10 U/ml of IL-12 in combination with
 
IL-2 at concentrations ranging from 0.05 to 500 U/ml(C and F). After incubation, the levels of IFN-γ(A, B, and C)and TNF-α(D, E, and
 
F)present in the supernatants were determined by enzyme-linked immunosorbent assay(ELISA).
Fig. 2  Time-dependent eﬀect of pulsing with IL-2 alone, IL-12
 
alone, and a combination of IL-12 and IL-2 on the production of IFN-γ
(A)and TNF-α(B)by peripheral blood lymphocytes(PBL). PBL(5×
10?cells/100μl/well)were cultured in the absence( )or presence
 
of IL-2(50 U/ml)( ), IL-12(10 U/ml)( ), or IL-2(50 U/ml)and
 
IL-12(10 U/ml)( )for 6, 12, 24, and 48 h. At the time indicated,
the cultured supernatants were harvested and assessed for the
 
production of IFN-γand TNF-α.
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(Fig. 3A). The analysis showed that there were signiﬁcant diﬀerences in IFN-γproduction between PBL stimulated by either IL-2 or IL-12, and those stimulated with a combination of IL-2 and IL-12(P＜0.0001 by the repeated measure ANOVA) (Fig. 3A). The IFN-γ
production of PBL stimulated by IL-12(normal subjects,
median＝6306 pg/ml;LC, 4300 pg/ml;HCC, 7632 pg/ml)was higher than that of PBL stimulated by IL-2
(normal, 751 pg/ml;LC, 3121 pg/ml;HCC, 822 pg/
ml)(P＜0.005 by Scheﬀe test). In addition, the IFN-γ
production of PBL pulsed by the combination of IL-2 and IL-12 (normal subjects, median＝14500 pg/ml;LC,
12978 pg/ml;HCC, 17140 pg/ml) was signiﬁcantly higher than that of PBL stimulated by either IL-2 or IL-12(P＜0.0001 by Scheﬀe test).
In addition, we found a signiﬁcant diﬀerence in TNF-α production among PBL stimulated either by IL-2, IL-12, or the combination of IL-2 and IL-12(P＜
0.0001 by repeated measure ANOVA). The TNF-α
productions of PBL stimulated by the combination of IL-2 and IL-12 (normal subjects, median＝340 pg/ml;
LC, 784 pg/ml;HCC, 710 pg/ml) were signiﬁcantly higher than those of PBL stimulated by IL-2 (normal subjects, 70 pg/ml;LC, 573 pg/ml;HCC, 115 pg/ml)
(P＝0.0002 by Scheﬀe test)and those of PBL stimulated by IL-12 alone(normal subjects, 130 pg/ml;LC, 586 pg/ml;HCC, 255 pg/ml)(P＝0.012 by Scheﬀe test)
(Fig. 3B). The analysis conﬁrmed that PBL derived from HCC patients could be activated as well as PBL derived from normal subjects by pulsing with the combina-
tion of IL-2 and IL-12.
α γ The studies further exam-
ine whether the expression of perforin and granzyme B,
which are proteins involved in relevant cell-mediated cytotoxicity, were enhanced in IL-2-and/or IL-12-
stimulated PBL obtained from normal subjects and HCC patients(Fig. 4). The expression of perforin and TNF-α
mRNA were readily detected in unstimulated PBL obtained from a HCC patient and those from a normal subject. The granzyme B mRNA was weakly expressed in PBL stimulated with 50 U/ml of IL-2, whereas no expression of IFN-γmRNA was observed after stimula-
tion with IL-2 alone. In PBL stimulated with 50 U/ml of IL-12, the expression of granzyme B and IFN-γmRNA were up-regulated, as well as the expression of perforin and TNF-αmRNA. Furthermore, as can be seen in Fig. 4, the mRNA encoding perforin, granzyme B,
TNF-α, and IFM-γwere markedly and signiﬁcantly enhanced in PBL stimulated with the combination of IL-2 and IL-12. There were no signiﬁcant diﬀerences in the expression of granzyme B mRNA and IFN-γmRNA between PBL obtained from normal subjects and those from HCC patients.
Fig.3  The production of IFN-γ(A)and TNF-α(B)by peripheral
 
blood lymphocytes (PBL)obtained from 9 normal subjects ( ), 4
 
patients with liver cirrhosis( ), and 9 patients with hepatocellular
 
carcinoma(HCC)( ). Peripheral blood lymphocytes(5×10?cells/
100μl/well)were cultured in the absence(Medium)or presence of
 
IL-2(50 U/ml)(IL-2), IL-12(10 U/ml)(IL-12), or IL-2(50 U/ml)and
 
IL-12 (10 U/ml) (IL-2＋IL-12) for 24 h. After the incubation, the
 
levels of IFN-γand TNF-αpresent in the supernatants were deter-
mined by ELISA. Medians are indicated with horizontal bars. The
 
vertical bars indicate the range, and the horizontal boundaries of the
 
boxes represent the ﬁrst and third quartiles.
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 Discussion
 
The development of new therapies such as immunoth-
erapy is essential to prevent the recurrence of HCC.
Recently, Takayama et al. reported that adoptive im-
munotherapy using autologous lymphocytes activated in vitro with recombinant IL-2 and anti-CD3 antibody decreased the frequency of the recurrence of HCC and improved recurrence-free outcomes following HCC sur-
gery by 18  compared with controls［16］. However,
the overall survival did not diﬀer signiﬁcantly between the immunotherapy group and the control group.
On the other hand, it was reported that the NK cell activity was signiﬁcantly decreased in HCC patients compared with that in the control subjects, which sug-
gested that preoperative NK cell activity will help predict recurrence and prognosis after hepatectomy in patients with HCC［11］. Also, Kawarabayashi et al. reported that the proportion of CD56＋ NKT cells and NK cells decreased in liver mononuclear cells derived from cirrhotic livers, which suggested that a decreased number of CD56＋ NKT cells and NK cells in cirrhotic livers may be related to their susceptibility to HCC［12］. From these ﬁndings, we conclude that adoptive immunotherapy based on activated NK cells and NKT cells may be a promising adjunctive strategy for avoiding the recurrence of hepatocellular carcinoma after curative treatment.
IL-12 is a heterodimeric cytokine that has been shown to cause the proliferation of activated T cells and NK
 
cells, to enhance the lytic activity of NK cells, and to induce IFN-γproduction by resting and activated T and NK cells［13-15, 17, 18］. In mouse models of HCC,
IL-12 gene therapy has been reported to elicit protective and therapeutic immunity against hepatocellular car-
cinoma. Intratumoral administration of mouse IL-12 vector elevated serum IL-12 and IFN-γ, induced more lymphocyte inﬁltration by NK cells and CD3＋cells into the tumor, and reduced the number of microvessels［19,
20］.
In this study, elevated IFN-γlevels were observed in the supernatants of PBL stimulated by IL-12 for 24 h compared with those stimulated by IL-2. In addition,
IL-12 pulsing was found to up-regulate the expression of their cytolytic component, granzyme B mRNA, compar-
ed with IL-2 pulsing. These observations suggest that pulsing with IL-12 can induce IFN-γproduction by T and NK cells and enhance the lytic activity of NK cells even in PBL obtained from patients with HCC.
Pulsing with a combination of IL-2 and IL-12 aug-
mented IFN-γand TNF-α production by PBL in a synergistic or cumulative manner. Also, the mRNA encoding perforin and granzyme B were markedly and signiﬁcantly enhanced in PBL pulsed with the combina-
tion of IL-2 and IL-12 for 24h in comparison with those pulsed with either IL-2 alone or IL-12 alone. The pulsing procedure of IL-12 in combination with IL-2 for 24 h resulted in increased IFN-γand TNF-αproduction and increased expression of perforin and granzyme B mRNA
 
Fig.4  Expression of perforin, granzyme B, TNF-α, and IFN-γmRNA in peripheral blood lymphocytes (PBL)stimulated by IL-2 and/or
 
IL-12. PBL obtained from a normal subject(1, 2, 3 and 4)and from a patient with hepatocellular carcinoma(HCC)(5, 6, 7 and 8)were
 
cultured in the absence(1 and 5)or presence of IL-2(50 U/ml)(2 and 6), IL-12(10 U/ml)(3 and 7), or IL-12(50 U/ml)plus IL-12(10 U/
ml)(4 and 8)for 24 h. Total RNA was prepared from activated PBL and analyzed by reverse transcription-polymerase chain reaction(RT-PCR)
for the expression of perforin, granzyme B, TNF-α, and IFN-γmRNA.
Sawayama et al. Acta Med. Okayama Vol. 57, No. 6 29 0
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in PBL obtained from HCC patients as well as in those obtained from normal subjects.
Chan et al.［21］reported that IL-12 synergizes with IL-2 in the accumulation of IFN-γmRNA in PHA-
activated T cell blasts and the T leukemia cell line TALL-103/2. Synergy between IL-2 and IL-12 can be demonstrated only at the level of mRNA stability, and both cytokines are required to increase IFN-γmRNA half-life. Also, in the human NK cell line NK3.3, IL-12 and IL-2 synergized in the induction of IFN-γ and granulocyte-macrophage colony-stimulating factor (GM-
CSF)and their synergy was attributed to an increased accumulation and stability of the IFN-γand GM-CSF mRNA［22］. In addition, it was reported that co-
incubation with IL-12 and IL-2 augmented IFN-γand TNF-αproduction by non-adherent mononuclear cells in a synergistic or cumulative manner, and also that the NK cell cytotoxicity was much more augmented by the co-
incubation of IL-12 and IL-2 than the incubation of IL-12 alone［23］.
Activated lymphocytes including NK cells might be essential for an anti-tumor eﬀect in vivo. Adoptive im-
munotherapy with enhanced natural cytotoxicity mediated NK cells might play an important role in host anticancer defense mechanisms in vivo. PBL pulsed with a combina-
tion of IL-2 and IL-12 could be used as eﬀector cells in adoptive immunotherapy, although the speciﬁcity of cytotoxic eﬀects of these activated PBL against HCC should be evaluated. In the treatment of HCC, a relative suﬃcient number of activated lymphocytes can be ad-
ministered to a liver containing HCC with reasonable safety by transcatheter injection. Also, activated lymphocytes can be continuously administered to the liver through a catheter placed into the hepatic artery. There-
fore, adoptive immunotherapy based on PBL pulsed with a combination of IL-2 and IL-12 may be a promising adjunctive strategy for HCC treatment.
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